BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Breast Cancer
,
Breast
,
Amniocentesis
,
Vitamin E
,
rs2476601
,
BRCA1
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
sphingomyelin phosphodiesterase activity
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Sigmoid colon
Transverse colon
Trigeminal ganglia
Rectum colon
Ascending colon
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Sphingomyelin/cholesterol lipidosis
Epithelial hyperplasia of skin
Vesicular stomatitis Indiana virus disease
Listeriosis
Edema
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
naphthalene
GSK690693
Antigens, Neoplasm
Pyrrolidines
ONO 2235
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
chico
SGPP1
SEC61A2
BCAR1
NAPEPLD
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Expression of the small intestine mucosa in respose to different levels of fat in the diet
The Immunological Genome Project - Immune cell lineage differentiation and maturation
RAW 264.7 macrophages treated with IFNγ, LPS, or 2-MA
Dorsal epidermis of mice after physical or immune-mediated epidermal injury
L1000 CMAP - Neural progenitor NPC cells treated with small molecule perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for sphingomyelin phosphodiesterase activity
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
PRI-VENT FSGS: Preemptive Rituximab to Prevent Recurrent Focal Segmental Glomerulosclerosis Post-Tra…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ